NCT00568399View on ClinicalTrials.gov

Sodium Thiosulfate Treatment of Vascular Calcification in ESRD

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Complication of HemodialysisCardiovascular Diseases
Interventions
DRUG

sodium thiosulfate

sodium thiosulfate 12.5-25 gm/M2 after each thrice weekly hemodialysis treatments for 5 months.

Trial Locations (1)

63110

Washington University, St Louis

All Listed Sponsors
collaborator

Barnes-Jewish Hospital

OTHER

collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT00568399 - Sodium Thiosulfate Treatment of Vascular Calcification in ESRD | Biotech Hunter | Biotech Hunter